Cetera Investment Advisers Has $2.62 Million Position in Zebra Technologies Corporation $ZBRA

Cetera Investment Advisers increased its stake in Zebra Technologies Corporation (NASDAQ:ZBRA) by 56.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,482 shares of the industrial products company’s stock after purchasing an additional 3,054 shares during the period. Cetera Investment Advisers’ holdings in Zebra Technologies were worth $2,616,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Trust Co. of Toledo NA OH acquired a new stake in shares of Zebra Technologies in the 2nd quarter valued at $25,000. Zions Bancorporation National Association UT acquired a new stake in Zebra Technologies in the first quarter worth about $27,000. Cary Street Partners Investment Advisory LLC bought a new stake in Zebra Technologies during the 1st quarter worth about $29,000. Brooklyn Investment Group lifted its position in Zebra Technologies by 101.9% during the 1st quarter. Brooklyn Investment Group now owns 107 shares of the industrial products company’s stock valued at $30,000 after purchasing an additional 54 shares during the period. Finally, Blue Trust Inc. boosted its stake in shares of Zebra Technologies by 81.7% in the 2nd quarter. Blue Trust Inc. now owns 109 shares of the industrial products company’s stock valued at $34,000 after purchasing an additional 49 shares during the last quarter. 91.03% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

ZBRA has been the subject of a number of recent research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Zebra Technologies in a research note on Wednesday, October 8th. Barclays lowered their target price on shares of Zebra Technologies from $375.00 to $360.00 and set an “overweight” rating for the company in a report on Wednesday, October 29th. Citigroup dropped their target price on shares of Zebra Technologies from $346.00 to $311.00 and set a “neutral” rating for the company in a research report on Wednesday, October 29th. Needham & Company LLC raised their price target on Zebra Technologies from $325.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Finally, Truist Financial decreased their price objective on Zebra Technologies from $350.00 to $331.00 and set a “hold” rating for the company in a research note on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $354.00.

Insider Activity

In other Zebra Technologies news, Director Satish Dhanasekaran acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The stock was acquired at an average cost of $233.12 per share, for a total transaction of $233,120.00. Following the transaction, the director owned 3,356 shares of the company’s stock, valued at $782,350.72. This trade represents a 42.44% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.84% of the company’s stock.

Zebra Technologies Trading Up 1.1%

Shares of NASDAQ ZBRA opened at $253.24 on Friday. Zebra Technologies Corporation has a twelve month low of $205.73 and a twelve month high of $427.76. The stock has a market cap of $12.83 billion, a price-to-earnings ratio of 25.53 and a beta of 1.80. The company has a quick ratio of 1.03, a current ratio of 1.61 and a debt-to-equity ratio of 0.56. The company’s fifty day moving average is $277.13 and its 200-day moving average is $299.45.

Zebra Technologies (NASDAQ:ZBRA) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $3.88 EPS for the quarter, topping the consensus estimate of $3.75 by $0.13. Zebra Technologies had a return on equity of 18.08% and a net margin of 9.74%.The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.32 billion. During the same quarter last year, the business posted $3.49 EPS. The firm’s revenue was up 5.2% compared to the same quarter last year. Zebra Technologies has set its Q4 2025 guidance at 4.200-4.400 EPS. FY 2025 guidance at 15.800-15.800 EPS. Equities research analysts predict that Zebra Technologies Corporation will post 13.71 EPS for the current year.

Zebra Technologies declared that its board has authorized a stock buyback plan on Tuesday, August 5th that authorizes the company to repurchase $250.00 million in shares. This repurchase authorization authorizes the industrial products company to buy up to 1.4% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

Zebra Technologies Company Profile

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.